What the Bay Area's first #IPO filing of 2024 could say about the year ahead in #biotech
#jpm24
#jpm2024
0
0
0
0
What the Bay Area's first #IPO filing of 2024 could say about the year ahead in #biotech
#jpm24
#jpm2024
$VCYT pays $70M upfront to buy Israeli company, potentially expand its #cancer testing platform
#jpm2024
#jpm24
www.bizjournals.com/sanfrancisco...
On my way to #JPM2024 week in San Francisco. Looking forward to reconnecting with old friends and partners, and meeting new ones!
Please send me a direct message in case you are interested in learning how our BioMed X Institutes in New Haven and Heidelberg solve big biomedical R&D challenges.